Skip to content

Evaluation of a novel approach for colorectal cancer screening using an intelligent tool (INTEL-PATH CRC)

Evaluation of appropriate techniques and strategies for risk-adapted colorectal cancer screening and early diagnosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086754
Enrollment
Unknown
Registered
2024-07-10
Start date
2024-07-20
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Cancer

Interventions

High risk/ Medium to low risk/ Positive FIT test/ Negative FIT test:None

Sponsors

Cancer Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 74 Years

Inclusion criteria

Inclusion criteria: 1. Habitant of the study region; 2. Aged 45-74 years old 3. Able to provide informed consent.

Exclusion criteria

Exclusion criteria: 1. Prior history of colorectal cancer 2. Prior history of colonic resection 3. Undertaking any kind of cancer related therapy (Except for non-melanoma skin cancer) 4. Prior colonic examination, including colonoscopy, flexible sigmoidoscopy, CT colonograpy and Barium enema within five years 5. Prior history of fecal occult blood test and fecal DNA test within 1 year 6. Symptoms of lower gastrointestinal tract disease warranting colonoscopic evaluation, including:1)More than one episode of rectal bleeding within the past 6 months; 2) Documented iron deficiency anemia; 3)Significant documented unintentional weight loss (>10% of baseline weight) over 6 months 7.Significant comorbidity that would preclude benefit from screening or pose significant risk for the performance of colonoscopy (e.g. severe lung disease, end-stage renal disease, end-stage liver disease, severe heart failure, recent diagnosis of cancer (with the exception of non-melanoma skin cancer))

Design outcomes

Primary

MeasureTime frame
Detection rate of advanced colorectal neoplasm (including colorectal cancer and advanced adenoma);Compliance rate of colorectal cancer screening;Detection rate of any colorectal adenoma;

Secondary

MeasureTime frame
Colorectal cancer incidence;Colorectal cancer mortality;

Countries

China

Contacts

Public ContactMin Dai

Cancer Hospital, Chinese Academy of Medical Sciences

daimin2002@hotmail.com010-8778 7408

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026